Table 1

Participant characteristics and accelerated long-term forgetting scores in cognitively-normal participants with complete biomarker data (n = 306)

Characteristicβ-Amyloid-negativeβ-Amyloid-positive
n21195
Percentage female49.852.6
Age at ALF assessment, years: mean, SD, (range)72.9, 0.64, (71.9, 74.7)72.9, 0.59, (71.9, 74.0)
Childhood cognitive ability, z-score: mean, SD, (range)0.48, 0.71, (−1.59, 2.47)0.34, 0.71, (−1.37, 2.50)
Highest educational qualification, %a
 None12.820.0
 Below O-levels (vocational)4.73.2
 O-levels or equivalent26.130.5
 A-levels or equivalent34.632.6
 Degree or equivalent21.813.7
Socioeconomic position, %
 Unskilled0.50
 Partly skilled5.25.3
 Skilled manual9.56.3
 Skilled non-manual21.824.2
 Intermediate52.655.8
 Professional10.48.4
Percentage APOE-ε4 carriersa19.154.7
Neuroimaging follow-up interval, years: mean, SD, (range)2.4, 0.2, (2.0, 3.2)2.4, 0.2, (2.2, 3.1)
White matter hyperintensity volume, ml: median, IQR, (range)4.1, 2.0–9.1, (0.1, 44.0)4.1, 2.0–9.1, (0.1, 44.0)
Whole-brain atrophy rateb, ml/year: mean, SD, (range)−5.7, 3.1, (−15.9, 3.6)−6.3, 2.9, (−14.1, −0.7)
Hippocampal atrophy rateb, ml/year: mean, SD, (range)−0.04, 0.04, (−0.22, 0.07)−0.04, 0.04, (−0.17, 0.04)
MyCog subjective cognitive decline score (out of 24): mean, SD, (range)4.5, 3.9, (0, 18)5.2, 4.0, (0, 21)
Change in MyCog score: mean, SD, (range)0.36, 3.1, (−10, 11)0.33, 2.7, (−7, 10)
Preclinical Alzheimer’s cognitive composite: mean, SD, (range)0.09, 0.62, (−1.8, 1.5)0.02, 0.66, (−1.9, 1.5)
 Accelerated long-term forgetting scores (%): mean, SD, [median], (range)
 Complex figure drawingtotal79, 16, [80], (12–122)77, 19, [76], (0–111)
 Complex figure drawingoutlinea96, 16, [100], (14–200)89, 17, [95], (0–118)
 Complex figure drawingdetail72, 22, [71], (11–157)71, 23, [71], (0–125)
 Face–name77, 21, [79], (0–200)76, 22, [79], (0–129)
Characteristicβ-Amyloid-negativeβ-Amyloid-positive
n21195
Percentage female49.852.6
Age at ALF assessment, years: mean, SD, (range)72.9, 0.64, (71.9, 74.7)72.9, 0.59, (71.9, 74.0)
Childhood cognitive ability, z-score: mean, SD, (range)0.48, 0.71, (−1.59, 2.47)0.34, 0.71, (−1.37, 2.50)
Highest educational qualification, %a
 None12.820.0
 Below O-levels (vocational)4.73.2
 O-levels or equivalent26.130.5
 A-levels or equivalent34.632.6
 Degree or equivalent21.813.7
Socioeconomic position, %
 Unskilled0.50
 Partly skilled5.25.3
 Skilled manual9.56.3
 Skilled non-manual21.824.2
 Intermediate52.655.8
 Professional10.48.4
Percentage APOE-ε4 carriersa19.154.7
Neuroimaging follow-up interval, years: mean, SD, (range)2.4, 0.2, (2.0, 3.2)2.4, 0.2, (2.2, 3.1)
White matter hyperintensity volume, ml: median, IQR, (range)4.1, 2.0–9.1, (0.1, 44.0)4.1, 2.0–9.1, (0.1, 44.0)
Whole-brain atrophy rateb, ml/year: mean, SD, (range)−5.7, 3.1, (−15.9, 3.6)−6.3, 2.9, (−14.1, −0.7)
Hippocampal atrophy rateb, ml/year: mean, SD, (range)−0.04, 0.04, (−0.22, 0.07)−0.04, 0.04, (−0.17, 0.04)
MyCog subjective cognitive decline score (out of 24): mean, SD, (range)4.5, 3.9, (0, 18)5.2, 4.0, (0, 21)
Change in MyCog score: mean, SD, (range)0.36, 3.1, (−10, 11)0.33, 2.7, (−7, 10)
Preclinical Alzheimer’s cognitive composite: mean, SD, (range)0.09, 0.62, (−1.8, 1.5)0.02, 0.66, (−1.9, 1.5)
 Accelerated long-term forgetting scores (%): mean, SD, [median], (range)
 Complex figure drawingtotal79, 16, [80], (12–122)77, 19, [76], (0–111)
 Complex figure drawingoutlinea96, 16, [100], (14–200)89, 17, [95], (0–118)
 Complex figure drawingdetail72, 22, [71], (11–157)71, 23, [71], (0–125)
 Face–name77, 21, [79], (0–200)76, 22, [79], (0–129)

ALF = accelerated long-term forgetting; IQR = interquartile range; SD = standard deviation.

aBased on t-test, ranksum tests or χ2 tests, as appropriate, the difference between amyloid-positive and amyloid-negative groups was statistically significant for education, APOE-ε4 and complex figure drawingoutline.

bAtrophy is represented as change in volume, with negative numbers indicating volume loss.

Table 1

Participant characteristics and accelerated long-term forgetting scores in cognitively-normal participants with complete biomarker data (n = 306)

Characteristicβ-Amyloid-negativeβ-Amyloid-positive
n21195
Percentage female49.852.6
Age at ALF assessment, years: mean, SD, (range)72.9, 0.64, (71.9, 74.7)72.9, 0.59, (71.9, 74.0)
Childhood cognitive ability, z-score: mean, SD, (range)0.48, 0.71, (−1.59, 2.47)0.34, 0.71, (−1.37, 2.50)
Highest educational qualification, %a
 None12.820.0
 Below O-levels (vocational)4.73.2
 O-levels or equivalent26.130.5
 A-levels or equivalent34.632.6
 Degree or equivalent21.813.7
Socioeconomic position, %
 Unskilled0.50
 Partly skilled5.25.3
 Skilled manual9.56.3
 Skilled non-manual21.824.2
 Intermediate52.655.8
 Professional10.48.4
Percentage APOE-ε4 carriersa19.154.7
Neuroimaging follow-up interval, years: mean, SD, (range)2.4, 0.2, (2.0, 3.2)2.4, 0.2, (2.2, 3.1)
White matter hyperintensity volume, ml: median, IQR, (range)4.1, 2.0–9.1, (0.1, 44.0)4.1, 2.0–9.1, (0.1, 44.0)
Whole-brain atrophy rateb, ml/year: mean, SD, (range)−5.7, 3.1, (−15.9, 3.6)−6.3, 2.9, (−14.1, −0.7)
Hippocampal atrophy rateb, ml/year: mean, SD, (range)−0.04, 0.04, (−0.22, 0.07)−0.04, 0.04, (−0.17, 0.04)
MyCog subjective cognitive decline score (out of 24): mean, SD, (range)4.5, 3.9, (0, 18)5.2, 4.0, (0, 21)
Change in MyCog score: mean, SD, (range)0.36, 3.1, (−10, 11)0.33, 2.7, (−7, 10)
Preclinical Alzheimer’s cognitive composite: mean, SD, (range)0.09, 0.62, (−1.8, 1.5)0.02, 0.66, (−1.9, 1.5)
 Accelerated long-term forgetting scores (%): mean, SD, [median], (range)
 Complex figure drawingtotal79, 16, [80], (12–122)77, 19, [76], (0–111)
 Complex figure drawingoutlinea96, 16, [100], (14–200)89, 17, [95], (0–118)
 Complex figure drawingdetail72, 22, [71], (11–157)71, 23, [71], (0–125)
 Face–name77, 21, [79], (0–200)76, 22, [79], (0–129)
Characteristicβ-Amyloid-negativeβ-Amyloid-positive
n21195
Percentage female49.852.6
Age at ALF assessment, years: mean, SD, (range)72.9, 0.64, (71.9, 74.7)72.9, 0.59, (71.9, 74.0)
Childhood cognitive ability, z-score: mean, SD, (range)0.48, 0.71, (−1.59, 2.47)0.34, 0.71, (−1.37, 2.50)
Highest educational qualification, %a
 None12.820.0
 Below O-levels (vocational)4.73.2
 O-levels or equivalent26.130.5
 A-levels or equivalent34.632.6
 Degree or equivalent21.813.7
Socioeconomic position, %
 Unskilled0.50
 Partly skilled5.25.3
 Skilled manual9.56.3
 Skilled non-manual21.824.2
 Intermediate52.655.8
 Professional10.48.4
Percentage APOE-ε4 carriersa19.154.7
Neuroimaging follow-up interval, years: mean, SD, (range)2.4, 0.2, (2.0, 3.2)2.4, 0.2, (2.2, 3.1)
White matter hyperintensity volume, ml: median, IQR, (range)4.1, 2.0–9.1, (0.1, 44.0)4.1, 2.0–9.1, (0.1, 44.0)
Whole-brain atrophy rateb, ml/year: mean, SD, (range)−5.7, 3.1, (−15.9, 3.6)−6.3, 2.9, (−14.1, −0.7)
Hippocampal atrophy rateb, ml/year: mean, SD, (range)−0.04, 0.04, (−0.22, 0.07)−0.04, 0.04, (−0.17, 0.04)
MyCog subjective cognitive decline score (out of 24): mean, SD, (range)4.5, 3.9, (0, 18)5.2, 4.0, (0, 21)
Change in MyCog score: mean, SD, (range)0.36, 3.1, (−10, 11)0.33, 2.7, (−7, 10)
Preclinical Alzheimer’s cognitive composite: mean, SD, (range)0.09, 0.62, (−1.8, 1.5)0.02, 0.66, (−1.9, 1.5)
 Accelerated long-term forgetting scores (%): mean, SD, [median], (range)
 Complex figure drawingtotal79, 16, [80], (12–122)77, 19, [76], (0–111)
 Complex figure drawingoutlinea96, 16, [100], (14–200)89, 17, [95], (0–118)
 Complex figure drawingdetail72, 22, [71], (11–157)71, 23, [71], (0–125)
 Face–name77, 21, [79], (0–200)76, 22, [79], (0–129)

ALF = accelerated long-term forgetting; IQR = interquartile range; SD = standard deviation.

aBased on t-test, ranksum tests or χ2 tests, as appropriate, the difference between amyloid-positive and amyloid-negative groups was statistically significant for education, APOE-ε4 and complex figure drawingoutline.

bAtrophy is represented as change in volume, with negative numbers indicating volume loss.

Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close